Objective: To investigate causal associations between diabetes, insulin treatment and osteoporosis using LDSC analysis with a 2-way Mendelian randomization study. Methods: LDSC analysis was used to estimate the likelihood-scale heritability of the genome-wide association study used with genetic correlation between the 2 genome-wide association study used. Then a 2-sample Mendelian randomization study was performed using 3 methods including inverse variance weighted, MR Egger, and weighted median. Results: The genetic correlation between diabetes, insulin treatment (h2_Z = 3.70, P = 2.16e−4), osteoporosis (h2_Z = 4.93, h2_p = 8.13e−7) and genes was significant. There was a significant genetic correlation (rg = 0.122, P = 0.0211). There was a causal association between diabetes, insulin treatment and osteoporosis [ P = 0.003754, OR (95%CI) = 0.998876 (0.998116−0.999636)], while no causal association existed between osteoporosis and insulin use ( P = 0.998116–0.999636) causal association existed ( P = 0.333244). Conclusion: There was a strong genetic correlation between diabetes, insulin treatment and osteoporosis, a causal association between diabetes, insulin treatment and osteoporosis, and no causal association between osteoporosis and diabetes, insulin treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: